Uveal Melanoma: A European Network to Face the Many Challenges of a Rare Cancer
There is no standard oncological treatment available for metastatic UM patients, and BRAF/MEK and immune checkpoint inhibitors show disappointing results when compared to cutaneous melanoma (CM).
Bizonyítékszint: Klinikai vizsgálat. Formális klinikai vizsgálati eredmény.
Kapcsolódó jelek
- Uveal melanoma as a target for immune-therapy
- Toward Precision Medicine: Gene Therapy Applications in the Management of Uveal Melanoma
- EORTC and Immunocore Announce Enrolment of First Patient onto the Only Active Phase 3 Adjuvant Trial in Uveal Melanoma
- Phase II Trial of Bevacizumab in Combination With Temozolomide as First-Line Treatment in Patients With Metastatic Uveal Melanoma
- Custom bipolar electrode for bleomycin-based electrochemotherapy in patient-derived uveal melanoma in ovo and ex vivo